Back to search

Peptide record

TPDB43116

CTX-23 Anticancer standard
36 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB43116
CTX-23
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 36-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
VCMPCFTTDQQMARKCSDCCGGKGRGKCYGPQCLCR
Physicochemical Analysis
C156H257N51O48S10
NEHIW
C
3935.67
8.31
6
2
7
+4
5.85
-0.417
21.67
Mammalian: 100 hour Yeast: >20 hour E.coli: >10 hour
1990
50.56
15
Residue Composition
number
1
A
3
R
0
N
2
D
8
C
0
E
3
Q
5
G
0
H
0
I
1
L
3
K
2
M
1
F
2
P
1
S
2
T
0
W
1
Y
1
V
Amino Acid Distribution
A: 1 R: 3 N: 0 D: 2 C: 8 E: 0 Q: 3 G: 5 H: 0 I: 0 L: 1 K: 3 M: 2 F: 1 P: 2 S: 1 T: 2 W: 0 Y: 1 V: 1
Chemical Descriptors
36
C156H257N51O48S10
3935.67
8.31
+4
5.85
-0.417
Free
L
Linear
Free
Anticancer
Synthetic
Evidence Records 1 records
Evidence 1 Activity

Activity

Graph Figure 2
Anticancer

Target

Brain Tumor
U-251
Brain

Assay & Model

MTT assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2016

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.